Senior insider sale
Chief Executive Officer at MOONLAKE IMMUNOTHERAPEUTICS — senior position signals high conviction
$2.79M
150K shares
What this filing means
SANTOS DA SILVA JORGE plans to sell 150K shares of MOONLAKE IMMUNOTHERAPEUTICS valued at approximately $2.79M. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 4/10/2026ACC: 0001969223-26-000439
DirectorOfficer· Chief Executive Officer
Since Apr 2022
150K
Shares to sell
$2.79M
Approx. market value
3.03M
Acquired (3 months)
1
Planned
Securities Acquired — Last 3 Months1
Exchange of Shares
Shares were obtained upon exchange from MLTX
10/1/2023
3.03MTotal acquired3.03M
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
10/1/2023 | Exchange of Shares Shares were obtained upon exchange from MLTX | 3.03M | — |
| Total | 3.03M | ||
Planned & Completed Dispositions1
NasdaqPlanned
Units to sell
150K
Market value
$2.79M
4/10/2026
Total
Units
150K
Value
$2.79M
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
4/10/2026 | 150K | $2.79M | Nasdaq | Planned |
| Total | 150K | $2.79M | ||